RE: Article re AGM6 Jun 2023 09:42
JT,
Saw your post yesterday, thinking about stuff, your thesis could be a strong possibility
Makes a lot of sense, Ingenuity is a risk on asset and maybe not suited for the markets just yet, grow via VC /JV style funding rather than PE - former use equity/cash latter love debt and we know MM doesn’t like debt as he loses control
Spin out Nutrition separate quote or trade sale , raise $ pay off the £140M to £180M debt saving £60M interest a year at group level
Beauty remains as THG, premium listing no debt
MM / QIA as you suggest buy Ingenuity, makes sense, in a rush of blood (MM style ) he went public with the £1B valuation of ingenuity by Apollo but we don’t know the context, if MM is planning a move like above he would need to explain the Apollo offer in more detail if he wants to offer below the £1B though